Buyer’s remorse: how OAS1 genetic variants acquired by modern humans make them vulnerable to severe COVID-19
After almost 2.5 years of the COVID-19 pandemic, we are still trying to understand the factors contributing to differences in disease severity and who should be treated with what, when, and why. Our paper addresses some of these questions from genetic, molecular, evolutionary, and clinical angles.
